Evolus Inc (NASDAQ:EOLS) has a beta value of 1.33 and has seen 1.0 million shares traded in the last trading session. The company, currently valued at $901.07M, closed the last trade at $14.23 per share which meant it lost -$0.53 on the day or -3.59% during that session. The EOLS stock price is -25.23% off its 52-week high price of $17.82 and 35.0% above the 52-week low of $9.25. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.98 million shares traded. The 3-month trading volume is 696.32K shares.
The consensus among analysts is that Evolus Inc (EOLS) is Buy stock at the moment, with a recommendation rating of 1.14. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 3 have rated it as a Hold, with 3 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is 0.01.
Evolus Inc (NASDAQ:EOLS) trade information
Sporting -3.59% in the red in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the EOLS stock price touched $14.23 or saw a rise of 4.62%. Year-to-date, Evolus Inc shares have moved 28.89%, while the 5-day performance has seen it change 5.56%. Over the past 30 days, the shares of Evolus Inc (NASDAQ:EOLS) have changed 31.15%. Short interest in the company has seen 5.93 million shares shorted with days to cover at 8.5.
Wall Street analysts have a consensus price target for the stock at $25, which means that the shares’ value could jump 43.08% from current levels. The projected low price target is $20.0 while the price target rests at a high of $27.0. In that case, then, we find that the current price level is -89.74% off the targeted high while a plunge would see the stock gain -40.55% from current levels.
Evolus Inc (EOLS) estimates and forecasts
Figures show that Evolus Inc shares have outperformed across the wider relevant industry. The company’s shares have gained 15.60% over the past 6 months, with this year growth rate of 62.50%, compared to 11.70% for the industry. Revenue growth from the last financial year stood is estimated to be 31.65%.
2 analysts offering their estimates for the company have set an average revenue estimate of 79M for the current quarter. 1 have an estimated revenue figure of 73.9M for the next ending quarter. Year-ago sales stood 61M and 59.33M respectively for this quarter and the next, and analysts expect sales will grow by 29.51% for the current quarter and 31.65% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 10.81% over the past 5 years.
EOLS Dividends
Evolus Inc is expected to release its next earnings report in February this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Evolus Inc (NASDAQ:EOLS)’s Major holders
Insiders own 12.31% of the company shares, while shares held by institutions stand at 79.38% with a share float percentage of 90.51%. Investors are also buoyed by the number of investors in a company, with Evolus Inc having a total of 223.0 institutions that hold shares in the company. The top two institutional holders are PERCEPTIVE ADVISORS LLC with over 5.75 million shares worth more than $62.43 million. As of 2024-06-30, PERCEPTIVE ADVISORS LLC held 9.7858% of shares outstanding.
The other major institutional holder is TANG CAPITAL MANAGEMENT LLC, with the holding of over 4.85 million shares as of 2024-06-30. The firm’s total holdings are worth over $52.59 million and represent 8.2443% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF . As of Sep 30, 2024 , the former fund manager holds about 2.66% shares in the company for having 1.68 shares of worth $23.97 million while later fund manager owns 1.54 shares of worth $21.95 million as of Nov 30, 2024 , which makes it owner of about 2.44% of company’s outstanding stock.
